Tevogen recently reissued topline results from its Proof-of-Concept (POC) clinical trial, conducted at Thomas Jefferson University Hospital in Philadelphia. This trial assessed the safety and ...
Research that spans clinical specialties and research disciplines beyond health and healthcare is a priority for planning equitable responses to manage future health shocks, argue Amitava Banerjee and ...
OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority ...